Company Filing History:
2 out of 79 
2 out of 147 Years Active: 2015-2017
Title: Koichi Iwamura: Innovator in T Cell Function Enhancement
Introduction
Koichi Iwamura is a notable inventor based in Tsu, Japan. He has made significant contributions to the field of immunotherapy, particularly in enhancing T cell functions. With a total of 2 patents, his work is paving the way for advancements in cancer treatment and immune response enhancement.
Latest Patents
Iwamura's latest patents focus on a method for enhancing the function of T cells. This method involves inhibiting the expression of programmed death-1 ligand 1 (PD-L1) and/or programmed death-1 ligand 2 (PD-L2) in T cells. The result is a function-enhanced T cell that can significantly improve immune responses to cancer. Furthermore, this innovation is useful in developing therapeutic agents that can treat or prevent infectious diseases and autoimmune diseases.
Career Highlights
Throughout his career, Koichi Iwamura has worked with esteemed institutions such as Mie University and Takara Bio Inc. His research has been instrumental in advancing the understanding of T cell functionality and its applications in immunotherapy.
Collaborations
Iwamura has collaborated with notable colleagues, including Hiroshi Shiku and Hiroaki Ikeda. These partnerships have contributed to the success of his research and innovations in the field.
Conclusion
Koichi Iwamura's work in enhancing T cell functions represents a significant advancement in immunotherapy. His innovative methods and collaborations continue to influence the landscape of cancer treatment and immune response enhancement.